Advertisement

Clinical Research in Cardiology

, Volume 101, Issue 3, pp 159–164 | Cite as

Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study

  • Andreas W. Schoenenberger
  • Renate Schoenenberger-Berzins
  • Christoph Auf der Maur
  • Paolo M. Suter
  • Athanasios Vergopoulos
  • Paul Erne
Original Paper

Abstract

Background

Diuretic treatment for heart failure may lead to an increased urinary thiamine excretion and in long-term thiamine deficiency, which may further compromise cardiac function. This study evaluated the effect of high dose thiamine supplementation in heart failure patients.

Methods

Nine patients with diuretic treatment for symptomatic chronic heart failure and a left ventricular ejection fraction (LVEF) <40% were randomly assigned to receive thiamine (300 mg/day) or placebo for 28 days. After a wash-out of 6 weeks, the patients crossed-over to a second treatment period. The primary outcome was a change in LVEF.

Results

Mean age was 56.7 ± 9.2 years (range 44.9–75.4 years). Baseline LVEF was similar for both treatment groups (29.5% in the thiamine group and 29.5% in the placebo group, P = 0.911). After 28 days of thiamine treatment, the LVEF increased to 32.8% which was significantly (P = 0.024) different from the LVEF in the placebo group (28.8%). This corresponds to a treatment effect for LVEF of 3.9% in absolute terms.

Conclusions

This study suggests that thiamine supplementation has beneficial effects on cardiac function in patients with diuretic drugs for symptomatic chronic heart failure. Subclinical thiamine deficiency is probably an underestimated issue in these outpatients.

Keywords

Thiamine Heart failure Diuretics Cross-over studies 

Notes

Acknowledgments

Andreas Schoenenberger was supported by a Forschungskolleg Geriatrie Grant from the Robert Bosch Foundation, Stuttgart, Germany.

Supplementary material

392_2011_376_MOESM1_ESM.doc (90 kb)
Supplementary material 1 (DOC 90 kb)

References

  1. 1.
    van-Kraaij DJ, Jansen RW, de-Gier JJ, Gribnai FW, Hoefnagels WH (1998) Prescription patterns of diuretics in Dutch community-dwelling elderly patients. Br J Clin Pharmacol 46:403–407PubMedCrossRefGoogle Scholar
  2. 2.
    Yui Y, Itokawa Y, Kawai C (1980) Furosemide-induced thiamine deficiency. Cardiovasc Res 14:537–540PubMedCrossRefGoogle Scholar
  3. 3.
    Rieck J, Halkin H, Almog S, Seligman H, Lubetsky A, Olchovsky D, Ezra D (1999) Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers. J Lab Clin Med 134:238–243PubMedCrossRefGoogle Scholar
  4. 4.
    Suter PM, Vetter W (2000) Diuretics and vitamin B1: are diuretics a risk factor for thiamin malnutrition? Nutr Rev 58:319–323PubMedCrossRefGoogle Scholar
  5. 5.
    Suter PM, Haller J, Hany A, Vetter W (2000) Diuretic use: a risk factor for subclinical thiamine deficiency in elderly patients. J Nutr Health Aging 4:69–71PubMedGoogle Scholar
  6. 6.
    Hanninen SA, Darling PB, Sole MJ, Barr A, Keith ME (2006) The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure. J Am Coll Cardiol 47:354–361PubMedCrossRefGoogle Scholar
  7. 7.
    Katare RG, Caporali A, Oikawa A, Meloni M, Emanueli C, Madeddu P (2010) Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway. Circ Heart Fail 3:294–305PubMedCrossRefGoogle Scholar
  8. 8.
    Gioda CR, Roman-Campos D, Carneiro-Júnior MA, da Silva KA, de Souza MO, Mendes LJ, Natali AJ, Cruz JS (2009) Impaired cellular contractile function in thiamine-deficient rat cardiomyocytes. Eur J Heart Fail 11:1126–1128PubMedCrossRefGoogle Scholar
  9. 9.
    Abelmann WH, Lorell BH (1989) The challenge of cardiomyopathy. J Am Coll Cardiol 13:1219–1239PubMedCrossRefGoogle Scholar
  10. 10.
    Seligmann H, Halkin H, Rauchfleisch S, Kaufmann N, Motro M, Vered Z, Ezra D (1991) Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Am J Med 91:151–155PubMedCrossRefGoogle Scholar
  11. 11.
    Shimon I, Almog S, Vered Z, Seligmann H, Shefi M, Peleg E, Rosenthal T, Motro M, Halkin H, Ezra D (1995) Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med 98:485–490PubMedCrossRefGoogle Scholar
  12. 12.
    Pfitzenmeyer P, Guilland JC, d’Athis P, Petit-Mernier C, Gaudet M (1994) Thiamine status of elderly patients with cardiac failure including the effects of supplementation. Int J Vitam Nutr Res 64:113–118PubMedGoogle Scholar
  13. 13.
    Witte KK, Nikitin NP, Parker AC, von Haehling S, Volk HD, Anker SD, Clark AL, Cleland JG (2005) The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 26:2238–2244PubMedCrossRefGoogle Scholar
  14. 14.
    Luers C, Wachter R, Kleta S, Uhlir M, Koschack J, Scherer M, Binder L, Herrmann-Lingen C, Zapf A, Kulle B, Kochen MM, Pieske B (2010) Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction. Clin Res Cardiol 99:217–226PubMedCrossRefGoogle Scholar
  15. 15.
    Schoenenberger AW, Kobza R, Jamshidi P, Zuber M, Abbate A, Stuck AE, Pfisterer M, Erne P (2009) Sudden cardiac death in patients with silent myocardial ischemia after myocardial infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]). Am J Cardiol 104:158–163PubMedCrossRefGoogle Scholar
  16. 16.
    Saguner AM, Dür S, Perrig M, Schiemann U, Stuck AE, Bürgi U, Erne P, Schoenenberger AW (2010) Risk factors promoting hypertensive crises: evidence from a longitudinal study. Am J Hypertens 23:775–780PubMedCrossRefGoogle Scholar
  17. 17.
    Gorelik O, Almoznino-Sarafian D, Shteinshnaider M, Alon I, Tzur I, Sokolsky I, Efrati S, Babakin Z, Modai D, Cohen N (2009) Clinical variables affecting survival in patients with decompensated diastolic versus systolic heart failure. Clin Res Cardiol 98:224–232PubMedCrossRefGoogle Scholar
  18. 18.
    Karapolat H, Demir E, Bozkaya YT, Eyigor S, Nalbantgil S, Durmaz B, Zoghi M (2009) Comparison of hospital-based versus home-based exercise training in patients with heart failure: effects on functional capacity, quality of life, psychological symptoms, and hemodynamic parameters. Clin Res Cardiol 98:635–642PubMedCrossRefGoogle Scholar
  19. 19.
    Schoenenberger AW, Radovanovic D, Stauffer JC, Windecker S, Urban P, Eberli FR, Stuck AE, Gutzwiller F, Erne P, Acute Myocardial Infarction in Switzerland Plus Investigators (2008) Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes: a cohort study. J Am Geriatr Soc 56:510–516PubMedCrossRefGoogle Scholar
  20. 20.
    Kamp O, Metra M, de Keulenaer GW, Pieske B, Conraads V, Zamorano J, Huysse L, Vardas PE, Böhm M, Dei Cas L (2010) Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: background, aims and design of the ELANDD study. Clin Res Cardiol 99:75–82PubMedCrossRefGoogle Scholar
  21. 21.
    Conen D, Chae CU, Guralnik JM, Glynn RJ (2010) Influence of blood pressure and blood pressure change on the risk of congestive heart failure in the elderly. Swiss Med Wkly 140:202–208PubMedGoogle Scholar
  22. 22.
    Muzzarelli S, Tobler D, Leibundgut G, Schindler R, Buser P, Pfisterer ME, Brunner-La Rocca HP (2009) Detection of intake of nonsteroidal anti-inflammatory drugs in elderly patients with heart failure. How to ask the patient? Swiss Med Wkly 139:481–485PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Andreas W. Schoenenberger
    • 1
  • Renate Schoenenberger-Berzins
    • 2
  • Christoph Auf der Maur
    • 2
  • Paolo M. Suter
    • 3
  • Athanasios Vergopoulos
    • 4
  • Paul Erne
    • 2
  1. 1.Division of Geriatrics, Department of General Internal Medicine, Inselspital, Bern University HospitalUniversity of BernBernSwitzerland
  2. 2.Department of CardiologyLuzerner KantonsspitalLucerne 16Switzerland
  3. 3.Clinic and Policlinic of Internal MedicineUniversity Hospital of ZurichZurichSwitzerland
  4. 4.Department of Clinical ChemistryUniversity Hospital of ZurichZurichSwitzerland

Personalised recommendations